Search results
X4 Pharmaceuticals’ bet on drug for ultra-rare disease pays off with FDA approval - Boston Business...
The Business Journals· 19 hours agoA Boston biotech has received FDA approval for the first approved treatment specifically for...
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 16 hours agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
US FDA approves X4 Pharmaceuticals' drug for immunodeficiency disease
Reuters via Yahoo Finance· 1 day agoApril 29 (Reuters) - The U.S. FDA has approved X4 Pharmaceuticals' drug to treat a rare genetic immunodeficiency disease, the company ...
California is joining with a New Jersey company to make a generic opioid overdose reversal drug
NBC Bay Area· 22 hours agoCalifornia will soon begin selling its own generic version of Narcan — the drug that can save...
State gets opioid-reversal drugs at big discount
The San Francisco Examiner· 14 hours agoCalifornia is partnering with a New Jersey-based pharmaceutical company to distribute more than 3 million twin-packs of opioid-reversal drugs across the...
...Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs - Vertex ...
Benzinga· 4 days agoVertex Pharmaceuticals Inc‘s VRTX blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 15 minutes agoViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nanomedicine company at the forefront of genetic therapies, today announces the appointment ...
California is joining with a New Jersey company to make a generic opioid overdose reversal drug
Quartz· 22 hours agoCalifornia will soon begin selling its own generic version of Narcan — the drug that can save...
West Pharmaceutical Services, Inc. (NYSE:WST) to Post Q3 2024 Earnings of $2.19 Per Share, William...
ETF DAILY NEWS· 9 hours agoWest Pharmaceutical Services, Inc. (NYSE:WST – Free Report) – William Blair lifted their Q3 2024 earnings per share estimates for shares of West Pharmaceutical< ...
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday? - Deciphera ...
Benzinga· 19 hours agoOn Monday, Japanese pharma company ONO Pharmaceutical agreed to acquire Deciphera Pharmaceuticals...